H.R.1947

TREAT PTSD Act Treatment and Relief through Emerging and Accessible Therapy for PTSD Act

Introduced·3/6/25

The TREAT PTSD Act mandates the provision of stellate ganglion block therapy to veterans and Armed Forces members diagnosed with post-traumatic.

The TREAT PTSD Act, or Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, requires the Secretary of Veterans Affairs and the Secretary of Defense to provide stellate ganglion block therapy to veterans and members of the Armed Forces diagnosed with post-traumatic stress disorder. This therapy is available to those enrolled in the patient enrollment system or the TRICARE program, respectively, and who have chosen to receive it after being informed of its risks and benefits.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Subcommittee on Health Committee
Next
Committee decision

Sponsors

Democratic CaucusRepublican Caucus

History

Mar 27, 2025

House

Referred to the Subcommittee on Health.

Mar 6, 2025

House

Introduced in House

Mar 6, 2025

House

Referred to the Committee on Armed Services, and in addition to the Committee on Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.